Vitrectomy. Disorders of vitreous body
Conditions
Interventions
Intervention 1: Intervention group A: The patients in this group received 5 mg/kg of Ringer lactate solution for each kilogram of body weight, using 5 mg/kg sodium Thiopental manufactured by Exir Comp
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Candidate for Vitrectomy surgery Age 40 to 80 years ASA class I and II Informed consent to enter the study
Exclusion criteria
Exclusion criteria: History for abusing the drugs, alcohol and psychedelics Known allergy to ketamine, Acetaminophen, and Metoclopramide History of mental illness and seizures Pregnancy and breastfeeding Body Mass Index (BMI) greater than 35 Taking painkillers 24 hours before surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of pain after the operation. Timepoint: Upon entering recovery, 30 minutes, 2 hours, 4 hours, 8 hours, 24 hours after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate. Timepoint: Upon entering recovery, 30 minutes, 2 hours, 4 hours, 8 hours, 24 hours after surgery. Method of measurement: Electrocardiogram.;Blood Pressure. Timepoint: Upon entering recovery, 30 minutes, 2 hours, 4 hours, 8 hours, 24 hours after surgery. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDariush Moradi Farsani
Esfahan University of Medical Sciences
Outcome results
None listed